Trial intelligence / Profile preview

Melatonin Gel in Immediate Implant Placement

NCT07869030Recruiting

Sponsor
Future University in Egypt
Start
Nov 2025
Primary completion
Jun 2027
Countries
1
01

Overview

Randomised trial of Mucomel in Alveolar bone loss (2 arms), sponsored by Future University in Egypt. Primary endpoints: Peri-Implant Bone Density at 6 months and Buccal Bone Thickness at 6 months. Started Nov 2025; status: recruiting.

02

Drugs

Mucomel
03

Conditions

Alveolar bone loss

Beyond the preview

Go deeper on NCT07869030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07869030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call